MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption
- PMID: 16280328
- DOI: 10.1074/jbc.M510156200
MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption
Abstract
MCP-1 (monocyte chemotactic protein-1) is a CC chemokine that is induced by receptor activator of NFkappaB ligand (RANKL) in human osteoclasts. In the absence of RANKL, treatment of human peripheral blood mononuclear cells with macrophage colony-stimulating factor and MCP-1 resulted in tartrate-resistant acid phosphatase (TRAP)-positive multinuclear cells that are positive for calcitonin receptor (CTR) and a number of other osteoclast markers, including nuclear factor of activated t cells, cytoplasmic, calcineurin-dependent 1 (NFATc1). Although NFATc1 was strongly induced by MCP-1 and was observed in the nucleus, MCP-1 did not permit the formation of bone-resorbing osteoclasts, although these cells had the typical TRAP(+)/CTR(+) multinuclear phenotype of osteoclasts. Despite a similar appearance to osteoclasts, RANKL treatment was required in order for TRAP(+)/CTR(+) multinuclear cells to develop bone resorption activity. The lack of bone resorption was correlated with a deficiency in expression of certain genes related to bone resorption, such as cathepsin K and MMP9. Furthermore, calcitonin blocked the MCP-1-induced formation of TRAP(+)/CTR(+) multinuclear cells as well as blocking osteoclast bone resorption activity, indicating that calcitonin acts at two stages of osteoclast differentiation. Ablation of NFATc1 in mature osteoclasts did not prevent bone resorption activity, suggesting NFATc1 is involved in cell fusion events and not bone resorption. We propose that the MCP-1-induced TRAP(+)/CTR(+) multinuclear cells represent an arrested stage in osteoclast differentiation, after NFATc1 induction and cellular fusion but prior to the development of bone resorption activity.
Similar articles
-
MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation.J Biol Chem. 2005 Apr 22;280(16):16163-9. doi: 10.1074/jbc.M412713200. Epub 2005 Feb 17. J Biol Chem. 2005. PMID: 15722361
-
Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES.J Cell Biochem. 2006 Feb 15;97(3):512-8. doi: 10.1002/jcb.20649. J Cell Biochem. 2006. PMID: 16211583
-
Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation.J Biomed Mater Res B Appl Biomater. 2005 Jul;74(1):582-8. doi: 10.1002/jbm.b.30244. J Biomed Mater Res B Appl Biomater. 2005. PMID: 15768436
-
The Role of Rosavin in the Pathophysiology of Bone Metabolism.Int J Mol Sci. 2024 Feb 9;25(4):2117. doi: 10.3390/ijms25042117. Int J Mol Sci. 2024. PMID: 38396794 Free PMC article. Review.
-
Epigenetic and transcriptional regulation of osteoclast differentiation.Bone. 2020 Sep;138:115471. doi: 10.1016/j.bone.2020.115471. Epub 2020 Jun 8. Bone. 2020. PMID: 32526404 Review.
Cited by
-
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.Curr Osteoporos Rep. 2019 Dec;17(6):538-547. doi: 10.1007/s11914-019-00545-7. Curr Osteoporos Rep. 2019. PMID: 31713180 Free PMC article. Review.
-
Abnormal inhibition of osteoclastogenesis by mesenchymal stem cells through the miR-4284/CXCL5 axis in ankylosing spondylitis.Cell Death Dis. 2019 Feb 25;10(3):188. doi: 10.1038/s41419-019-1448-x. Cell Death Dis. 2019. PMID: 30804325 Free PMC article.
-
Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.Am J Pathol. 2011 Sep;179(3):1157-70. doi: 10.1016/j.ajpath.2011.05.034. Epub 2011 Jul 21. Am J Pathol. 2011. PMID: 21771572 Free PMC article.
-
EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix.J Cell Biochem. 2011 Jul;112(7):1749-60. doi: 10.1002/jcb.23094. J Cell Biochem. 2011. PMID: 21381079 Free PMC article.
-
Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis.Nat Med. 2009 Apr;15(4):417-24. doi: 10.1038/nm.1945. Epub 2009 Mar 29. Nat Med. 2009. PMID: 19330010
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous